Anti-MAdCAM antibody for induction of remission in ulcerative colitis

Author:

Rosenfeld Greg1,Bressler Brian1,Parker Claire E2,MacDonald John K2,Baumgart Daniel C3,Vermeire Séverine4,Feagan Brian G2

Affiliation:

1. University of British Columbia; Division of Gastroenterology; 770-1190 Hornby Street Vancouver BC Canada V6Z 2K5

2. Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London ON Canada N6A 5K8

3. Charité Medical School, Humboldt-University of Berlin; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology; Augustenburger Platz 1 Berlin Germany 13353

4. University of Leuven; Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical)

Reference36 articles.

1. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis;Ariyaratnam;American Journal of Gastroenterology,2014

2. Natalizumab for the treatment of Crohn's disease;Bickston;Expert Review of Clinical Immunology,2010

3. Vedolizumab for induction and maintenance of remission in ulcerative colitis;Bickston;Cochrane Database of Systematic Reviews,2014

4. Ulcerative colitis;Danese;New England Journal of Medicine,2011

5. Bias in meta-analysis detected by a simple, graphical test;Egger;BMJ,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3